970*90
768
468
mobile

Aurobindo Pharma May Set $100mn Deal With Apotex

Franchise India Bureau
Franchise India Bureau Feb 21 2018 - 1 min read
Aurobindo Pharma May Set $100mn Deal With Apotex
The pharma company is expecting a funding of $100 million and fits in with Aurobindo’s strategic road map of upping its presence in Eastern Europe.

Aurobindo Pharma is eyeing US $1.7-billion privately held European Business in the form of a Canadian Drug Maker Apotex. Known for its high profile litigations in the US against MNC pharma players, Apotex has put on the block its European operations as part of a wider consolidation effort

According to the sources who spoke to the newsperson, the pharma company is expecting a funding of US $100 million and fits in with Aurobindo’s strategic road map of upping its presence in Eastern Europe through bolt-on acquisitions. No other information could be elicited from the I-bankers.

Subscribe Newsletter
Submit your email address to receive the latest updates on news & host of opportunities
Entrepreneur Magazine

For hassle free instant subscription, just give your number and email id and our customer care agent will get in touch with you

or Click here to Subscribe Online